These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence. Ekpu VU; Brown AK Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225 [TBL] [Abstract][Full Text] [Related]
27. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Dempsey DA; Benowitz NL Drug Saf; 2001; 24(4):277-322. PubMed ID: 11330657 [TBL] [Abstract][Full Text] [Related]
28. Motivating smokers at outdoor public smoking hotspots to have a quit attempt with a nicotine replacement therapy sample: study protocol for a randomized controlled trial. Cheung YT; Leung JP; Cheung CK; Li WH; Wang MP; Lam TH Trials; 2016 Jul; 17(1):355. PubMed ID: 27456342 [TBL] [Abstract][Full Text] [Related]
29. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua. Lutz MA; Lovato P; Cuesta G Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881 [TBL] [Abstract][Full Text] [Related]
30. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction. Kozlowski LT Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913 [TBL] [Abstract][Full Text] [Related]
32. The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum"). Oster G; Delea TE; Huse DM; Regan MM; Colditz GA Med Care; 1996 May; 34(5):389-402. PubMed ID: 8614162 [TBL] [Abstract][Full Text] [Related]
33. A modeling approach to gauging the effects of nicotine vaping product use on cessation from cigarettes: what do we know, what do we need to know? Levy DT; Yuan Z; Li Y; Alberg AJ; Cummings KM Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):86-96. PubMed ID: 30548714 [TBL] [Abstract][Full Text] [Related]
34. Use of additional nicotine replacement therapy by participants in a five-year follow-up of a tobacco cessation trial. Cunningham JA; Kushnir V; Selby P; Zawertailo L; Tyndale RF; Leatherdale ST; Godinho A; Schell C Addict Behav; 2021 Jun; 117():106875. PubMed ID: 33639391 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Song F; Raftery J; Aveyard P; Hyde C; Barton P; Woolacott N Med Decis Making; 2002; 22(5 Suppl):S26-37. PubMed ID: 12369228 [TBL] [Abstract][Full Text] [Related]
37. Is the apparently protective effect of maternal nicotine replacement therapy (NRT) used in pregnancy on infant development explained by smoking cessation?: secondary analyses of a randomised controlled trial. Iyen B; Vaz LR; Taggar J; Cooper S; Lewis S; Coleman T BMJ Open; 2019 Jul; 9(7):e024923. PubMed ID: 31300493 [TBL] [Abstract][Full Text] [Related]
38. Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts. Levy DE; Thorndike AN; Biener L; Rigotti NA Tob Control; 2007 Dec; 16(6):384-9. PubMed ID: 18048614 [TBL] [Abstract][Full Text] [Related]
39. Long-term effectiveness of mailed nicotine replacement therapy: study protocol of a randomized controlled trial 5-year follow-up. Kushnir V; Selby P; Zawertailo L; Tyndale RF; Leatherdale ST; Cunningham JA BMC Public Health; 2017 Jul; 18(1):28. PubMed ID: 28720080 [TBL] [Abstract][Full Text] [Related]
40. Delivery of a Nicotine Replacement Therapy Sample at Outdoor Smoking Hotspots for Promoting Quit Attempts: A Pilot Randomized Controlled Trial. Cheung YTD; Cheung Li WH; Wang MP; Lam TH Nicotine Tob Res; 2020 Aug; 22(9):1468-1475. PubMed ID: 31404466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]